arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Pennant Group, Inc.

PNTG
$38.99 ▼ -0.03 (-0.06%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
9 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Neutral
auto_awesome

Analytical Summary

Pennant Group, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.3B
Dividend Yield
Revenue Growth 36.3%
Op. Margin 5.5%
ROIC 22.7%
FCF / Share $1.05
Trailing P/E 45.3x
Price / Book
FCF Yield 2.7%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$947.71M
↑ +36.3%
Net Income Profit after all expenses
$29.58M
↑ +31.1%
Operating Margin Operating profit as % of sales
5.5%
— -0.1% 44th
FCF / Share Free cash flow per share
$1.05
↑ +8.0%
Long-Term Debt Long-term obligations
$168.84M

Health Breakdown

Profitability
42
Financial Health
83
Cash Quality
73

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 32 quarters